Unusual Prenatal Genomic Results Provide Proof-of-Principle of the Liquid Biopsy for Cancer Screening
- PMID: 29237713
- PMCID: PMC6733018
- DOI: 10.1373/clinchem.2017.282459
Unusual Prenatal Genomic Results Provide Proof-of-Principle of the Liquid Biopsy for Cancer Screening
Conflict of interest statement
Dr. Bianchi has no conflicts of interest. She is an employee of the US federal government.
Comment on
-
Incidental Detection of Maternal Neoplasia in Noninvasive Prenatal Testing.Clin Chem. 2018 Feb;64(2):329-335. doi: 10.1373/clinchem.2017.277517. Epub 2017 Oct 5. Clin Chem. 2018. PMID: 28982650
References
-
- Murkoff H, Mazel S. What to Expect When You’re Expecting. 5th Edition New York: Workman Publishing Co., 2016.
-
- Dharajiya NG, Grosu DS, Farkas DH, et al. Incidental detection of maternal neoplasia in non-invasive prenatal testing. Clin Chem 2017; in press. - PubMed
-
- Vermeesch JR, Voet T, Devriendt K. Prenatal and pre-implantation genetic diagnosis. Nat Rev Genet 2016; 17: 643–656. - PubMed
-
- Mennuti MT, Cherry AM, Morrissette JJ, Dugoff L. Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy? Am J Obstet Gynecol 2013; 209:4150419. - PubMed
-
- Prasad V. Non-invasive, serum DNA pregnancy testing leading to incidental discovery of cancer: a good thing? Eur J Cancer 2015; 51:2272–2274. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
